Pfizer Inc (PFE)
26.71
+0.35
(+1.33%)
USD |
NYSE |
Dec 23, 16:00
26.74
+0.03
(+0.11%)
After-Hours: 20:00
Pfizer Research and Development Expense (Quarterly): 2.598B for Sept. 30, 2024
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
Amgen Inc | 1.45B |
Gilead Sciences Inc | 1.395B |
Johnson & Johnson | 4.952B |
Eli Lilly and Co | 2.734B |
Moderna Inc | 1.137B |